Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice
Nirmatrelvir/ritonavir (Paxlovid) is indicated in patients who are at high risk of progressing to severe COVID-19. Many of these patients are concomitantly prescribed various medications for other indications. Ritonavir has no activity against SARS-CoV-2, but, administered with nirmatrelvir, acts as...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Termedia Publishing House
2023-09-01
|
| Серія: | Family Medicine & Primary Care Review |
| Предмети: | |
| Онлайн доступ: | https://www.termedia.pl/Managing-nirmatrelvir-ritonavir-Paxlovid-interactions-in-general-practice,95,51167,1,1.html |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|